N. prodotti: 0
Totale ordine: € 0,00
A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413
Online ISSN 1827-1936
THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E.
Berk F., Demir H., Aktolun C
Department of Nuclear Medicine, Kocaeli University, School of Medicine, Kocaeli, Turkey
The advantages and limitations of 201Tl imaging in assessing the tumor response to anti-cancer therapy are discussed in this review. 201Tl has distinctive advantages but more recent agents such as 99mTc MIBI and positron emitters have some clinical superiorities over 201Tl in this usage.